Peter Palmer

2.7k total citations
57 papers, 2.0k citations indexed

About

Peter Palmer is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Peter Palmer has authored 57 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 14 papers in Immunology and 11 papers in Surgery. Recurrent topics in Peter Palmer's work include Cancer Immunotherapy and Biomarkers (16 papers), Immunotherapy and Immune Responses (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). Peter Palmer is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Immunotherapy and Immune Responses (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). Peter Palmer collaborates with scholars based in United States, Netherlands and United Kingdom. Peter Palmer's co-authors include B Hazelton, Robert Birch, Cathy Allen, W. H. West, Lee S. Schwartzberg, C H Weaver, Juan José Pérez Ruixo, C.R. Franks, C.J. Bol and R. Oskam and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Advanced Functional Materials.

In The Last Decade

Peter Palmer

54 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Palmer United States 18 1.1k 577 571 380 273 57 2.0k
Lance Leopold United States 24 1.4k 1.3× 1.1k 1.9× 473 0.8× 594 1.6× 435 1.6× 50 2.8k
Arthur C. Louie United States 17 1.1k 1.0× 1.2k 2.1× 793 1.4× 458 1.2× 802 2.9× 64 2.9k
Christopher A. Slapak United States 23 1.3k 1.2× 1.1k 2.0× 193 0.3× 194 0.5× 247 0.9× 42 2.3k
G. Stehle Germany 21 698 0.6× 788 1.4× 258 0.5× 199 0.5× 208 0.8× 53 2.0k
Akos Czibere United States 29 1.2k 1.1× 1.0k 1.8× 804 1.4× 326 0.9× 545 2.0× 112 2.6k
Robert J. Belt United States 20 1.5k 1.4× 789 1.4× 212 0.4× 164 0.4× 459 1.7× 59 2.6k
Judy H. Chiao United States 17 1.2k 1.1× 2.6k 4.5× 507 0.9× 285 0.8× 387 1.4× 40 3.5k
Edward M. Newman United States 26 1.2k 1.1× 1.1k 1.9× 156 0.3× 165 0.4× 431 1.6× 88 2.4k
Christian Jakob Germany 31 1.2k 1.1× 1.5k 2.6× 1.3k 2.2× 130 0.3× 199 0.7× 77 2.7k
Sonia Vallet United States 31 1.5k 1.3× 1.8k 3.1× 1.4k 2.4× 345 0.9× 190 0.7× 104 3.3k

Countries citing papers authored by Peter Palmer

Since Specialization
Citations

This map shows the geographic impact of Peter Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Palmer more than expected).

Fields of papers citing papers by Peter Palmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Palmer. The network helps show where Peter Palmer may publish in the future.

Co-authorship network of co-authors of Peter Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Palmer. A scholar is included among the top collaborators of Peter Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Palmer. Peter Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Palmer, Peter, et al.. (2024). Using Finite Element Models to Assess Spinal Cord Biomechanics after Cervical Laminoplasty for Degenerative Cervical Myelopathy. Diagnostics. 14(14). 1497–1497. 1 indexed citations
3.
4.
5.
Choi, Ki Young, Santiago Correa, Jouha Min, et al.. (2019). Binary Targeting of siRNA to Hematologic Cancer Cells In Vivo Using Layer‐by‐Layer Nanoparticles. Advanced Functional Materials. 29(20). 94 indexed citations
6.
Sparreboom, Alex, Diederik F.S. Kehrer, Ron H.J. Mathijssen, et al.. (2004). Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor. British Journal of Cancer. 90(8). 1508–1515. 13 indexed citations
7.
Crul, Mirjam, G.J.M. de Klerk, Louis M. Weiner, et al.. (2002). Evaluation of the bioequivalence of tablets and capsules containing the novel anticancer agent R115777 (Zarnestra) in patients with advanced solid tumors. European Journal of Drug Metabolism and Pharmacokinetics. 27(1). 61–65. 8 indexed citations
8.
Zuylen, Lia van, Alex Sparreboom, Ate van der Gaast, et al.. (2002). Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933. European Journal of Cancer. 38(8). 1090–1099. 55 indexed citations
9.
Mattijssen, Vera, P H de Mulder, Alexander de Graeff, et al.. (1994). Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinoma. Annals of Oncology. 5(10). 957–960. 19 indexed citations
10.
11.
Ardizzoni, Andrea, Editta Baldini, Anna Verna, et al.. (1994). Biologic and clinical effects of continuous infusion interleukin-2 in patients with non-small cell lung cancer. Cancer. 73(5). 1353–1360. 27 indexed citations
12.
13.
Palmer, Peter, Pauline Evers, R. Oskam, et al.. (1992). Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinoma. European Journal of Cancer. 28(6-7). 1038–1044. 56 indexed citations
14.
15.
Fiedler, Walter, D. K. Hossfeld, C Jasmin, et al.. (1992). A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanoma. European Journal of Cancer. 28(2-3). 443–446. 15 indexed citations
16.
Tubaro, Andrea, Carlo Vicentini, Lucio Miano, et al.. (1991). Continuous intra-arterial administration of recombinant interleukin-2 in low-stage bladder cancer. A phase IB study. Cancer. 68(1). 56–61. 13 indexed citations
17.
Atzpodien, Jens, et al.. (1990). Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-α. Annals of Oncology. 1(5). 377–378. 15 indexed citations
18.
Panici, P. Benedetti, Giovanni Scambia, Stefano Greggi, et al.. (1989). Recombinant interleukin-2 continuous infusion in ovarian cancer patients with minimal residual disease at second-look. Cancer Treatment Reviews. 16. 123–127. 4 indexed citations
19.
Anderson, H., John Wagstaff, D. Crowther, et al.. (1988). Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer. European Journal of Cancer and Clinical Oncology. 24(9). 1471–1479. 67 indexed citations
20.
Widmann, Warren D., et al.. (1981). Inhibition of Programmable Demand Pacemaker by Pacemaker-Induced Myopotentials. CHEST Journal. 80(3). 328–331. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lance Leopold Breakdown of academic impact, for papers by Arthur C. Louie Breakdown of academic impact, for papers by Christopher A. Slapak Breakdown of academic impact, for papers by G. Stehle Breakdown of academic impact, for papers by Akos Czibere Breakdown of academic impact, for papers by Robert J. Belt Breakdown of academic impact, for papers by Judy H. Chiao Breakdown of academic impact, for papers by Edward M. Newman Breakdown of academic impact, for papers by Christian Jakob Breakdown of academic impact, for papers by Sonia Vallet
Rankless by CCL
2026